Cure My Disease

Don't miss your cure!

 Log in / Sign up

Proactive pharmacist calls could help HIV patients kick the habit

NCT ID NCT05019495

Recruiting now Disease control Sponsor: Medical University of South Carolina Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a proactive approach to help people living with HIV quit smoking. A pharmacist calls participants, offers counseling, and sends cessation medication unless they opt out. The goal is to see if this method works better than standard care. The trial involves 231 adult smokers with HIV.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Proactive pharmacist counseling and medication opt-out program
What this could lead to
If successful, this could provide an effective way to help people with HIV quit smoking, reducing their risk of smoking-related diseases.
What could go wrong
This is a behavioral intervention trial, not a drug test. Results depend on patient engagement, and the study is relatively small (231 participants).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS Cigarette Smoking HIV infectious disease nicotine dependence Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV SMOKING ( CIGARETTE)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

    Contact Phone: •••-•••-••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.